Aurora Cannabis Inc. (TSX:ACB)
Canada · Delayed Price · Currency is CAD | Market Cap | 269.18M -17.9% |
| Revenue (ttm) | 314.07M +12.3% |
| Net Income | -120.13M |
| EPS | -2.07 |
| Shares Out | 64.86M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 136,417 |
| Open | 4.140 |
| Previous Close | 4.150 |
| Day's Range | 4.000 - 4.230 |
| 52-Week Range | 3.590 - 9.330 |
| Beta | 1.34 |
| Analysts | Buy |
| Price Target | 5.56 (+38.83%) |
| Earnings Date | Aug 5, 2026 |
About Aurora Cannabis
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient ... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsAnalyst Summary
According to 6 analysts, the average rating for ACB stock is "Buy." The 12-month stock price target is $5.56, which is an increase of 38.83% from the latest price.
News
Aurora, a Global Leader in Medical Cannabis, Announces Results of 2026 Annual General Meeting
EDMONTON, AB, Aug. 10, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) ("Aurora" or the "Company"), the Canadian-based leading global medical cannabis company, is pleased to announc...
Aurora Cannabis Shareholders Approve Board as Fiscal 2026 Results Beat Outlook
Aurora Cannabis NASDAQ: ACB said shareholders approved all items presented at its annual general meeting, including setting the board size at five directors, electing the company's nominees, reappoint...
Aurora Cannabis Shareholders Approve Board as Fiscal 2026 Results Beat Outlook
Profit from the Green Wave: Top Cannabis Stocks to WatchAurora Cannabis (NASDAQ:ACB) said shareholders approved all items presented at its annual general meeting, including setting the board size at f...
Aurora Cannabis Transcript: AGM 2026
The AGM reviewed strong fiscal 2026 results, with double-digit revenue growth, improved margins, and a robust cash position. All management proposals passed, including director elections and auditor appointment. Strategic focus remains on global medical cannabis leadership and international expansion.
Aurora Cannabis Q1 Earnings Call Highlights
Aurora Cannabis NASDAQ: ACB reported fiscal first-quarter 2027 net revenue of C$67.6 million, as growth in international medical cannabis sales was offset by lower Canadian medical revenue following r...
Aurora Cannabis Q1 Earnings Call Highlights
Profit from the Green Wave: Top Cannabis Stocks to WatchAurora Cannabis (NASDAQ:ACB) reported fiscal first-quarter 2027 net revenue of C$67.6 million, as growth in international medical cannabis sales...
Aurora Cannabis Earnings Call Transcript: Q1 2027
International medical cannabis revenue grew 17% year-over-year, now representing 64% of total net revenue, while consolidated adjusted gross margin reached 58%. Despite Canadian reimbursement headwinds, strong international performance and the Safari acquisition support a positive outlook for sequential growth.
Aurora Cannabis Registration statement: Q1 2027
Aurora Cannabis filed a registration statement on August 5, 2026, providing details about a securities offering with the SEC.
Aurora Cannabis Registration statement: Q1 2027
Aurora Cannabis filed a registration statement on August 5, 2026, providing details about a securities offering with the SEC.
Aurora Cannabis Earnings release: Q1 2027
Aurora Cannabis released its Q1 2027 earnings on August 5, 2026, summarizing the period's financial results.
Aurora Cannabis Slides: Q1 2027
Aurora Cannabis has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 5, 2026.
Aurora Cannabis Earnings release: Q1 2027
Aurora Cannabis released its Q1 2027 earnings on August 5, 2026, summarizing the period's financial results.
Aurora Cannabis reports Q1 revenue C$67.6M vs. C$74.1M last year
The 9% decrease was mainly due to lower quarterly net revenue in Canadian medical cannabis and the wind down in consumer cannabis, offset by higher net revenue in international medical…
Aurora Cannabis Announces Fiscal 2027 First Quarter Results
NASDAQ | TSX: ACB Delivers Net Revenue of $67.6 million, including a 17% YoY Increase in International Medical Cannabis Net Revenue Safari Flower Company Receives Three-Year EU-GMP Certification, Stre...
3 Canadian Marijuana Stocks Can Make You Big Gains
Aurora Cannabis Inc. (ACB) Receives ISS Support for Upcoming Shareholder Vote
Aurora Cannabis Inc. (ACB) Receives ISS Support for Upcoming Shareholder Vote
Aurora Cannabis (ACB) Receives Support from Proxy Advisory Firm
Aurora Cannabis (ACB) Receives Support from Proxy Advisory Firm
Aurora Cannabis’ board nominees and resolutions recommended by ISS
Aurora Cannabis (ACB) announced that Institutional Shareholder Services, or ISS, an independent proxy advisory firm, has recommended that Aurora’s shareholders vote for all resolutions set forth in th...
Aurora Receives Support from Leading Independent Proxy Adviser Institutional Shareholder Services Inc. for the 2026 Annual General Meeting of Shareholders
ISS has recommended that Aurora's shareholders vote FOR all director nominees and meeting resolutions Shareholders are encouraged to vote early in favour of all resolutions – every vote matters, no ma...
Aurora Cannabis (ACB) Secures EU Certification for Ontario Facility
Aurora Cannabis (ACB) Secures EU Certification for Ontario Facility
Aurora Cannabis unit receives EU-GMP certification at Ontario Facility
Safari Flower Company, a wholly owned subsidiary of Aurora Cannabis (ACB), is proud to announce the receipt of European Union Good Manufacturing Practice certification for its Ontario facility, solidi...
Safari Flower Company, a Wholly Owned Subsidiary of Aurora Cannabis, Receives EU-GMP Certification at Niagara Facility
The achievement strengthens Safari's ability to serve international medical cannabis markets under the strictest regulations EDMONTON, AB, July 23, 2026 /PRNewswire/ -- Safari Flower Company ("Safari"...
Aurora Cannabis to Host First Quarter 2027 Investor Conference Call
NASDAQ | TSX: ACB EDMONTON, AB, July 22, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, ann...
Aurora Named to TIME Canada's Best Companies 2026 List
NASDAQ | TSX: ACB The Company makes history as the first and only cannabis company to ever receive this recognition EDMONTON, AB, July 9, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: A...
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders
Shareholders are encouraged to keep an eye out for their meeting materials and vote early – every vote matters, no matter how many shares you own. Shareholders who have questions or need assistance w...